Evidence map›Paper›PMID 42420718›Full record

ReviewAdvances in experimental medicine and biology2026

Therapeutic Hypothermia for Neurological Injuries: Balancing Neuroprotection with Risks.

Liang Zhu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Liang ZhuDepartment of Mechanical Engineering, University of Maryland, Baltimore County, Baltimore, MD, USA. zliang@umbc.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While the therapeutic potential of hypothermia for treating tissue damage has been investigated for over 90 years, its effectiveness is still debated. This review introduces the history of hypothermia in medicine first, followed by a description of cellular mechanisms behind its neuroprotective effects observed in animal studies and some clinical studies. The next section focuses on current cooling approaches/devices, as well as cooling parameters recommended by researchers and clinicians to maximize the benefits of hypothermia. Animal and clinical studies of implementing hypothermia for spinal cord and brain tissue injury are presented next. The outcomes in treating conditions like traumatic brain injury (TBI), spinal cord injury (SCI), stroke, and cardiopulmonary issues will be discussed in detail. The review also examines the risks and benefits of hypothermia, supported or disputed by clinical studies. Contributions from bioengineers in the research field are presented in the last section, with details of cooling device design and theoretical simulations. Ultimately, the review highlights that successful hypothermia treatment hinges on achieving targeted tissue cooling quickly after injury, with mild hypothermia often being proven as effective as deeper cooling, provided a slow rewarming rate is implemented.

Indexed as

Brain Injuries, TraumaticHypothermia, InducedNeuroprotectionSpinal Cord InjuriesStrokeAnimalsHumansRisk FactorsBioengineeringBrain injuryCoolingCooling deviceHypothermia

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.